Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

baloramotide

A genetically engineered synthetic protein, recombinant NY-ESO-1 protein (cancer-testis tumor antigen family) elicits strong humoral and cellular immune responses to NY-ESO-1-expressing cancers and is used to produce specific vaccines to increase the immune response against tumors. NY-ESO-1 epitopes presented by human HLA are recognized by CD4(+) T lymphocytes in patients with NY-ESO-1-expressing melanoma.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	cancer/testis antigen 1, recombinant recombinant NY-ESO-1 protein

baloramotide

Search NCI's Drug Dictionary